Wall Street’s Top Analysts Upgrades, Downgrades & Initiations

Wall Street’s Top Analysts Upgrades, Downgrades & Initiations

$BUD, $ADM, $CG, $FENC, $INTU

Daily HeffX-LTN reviews Wall Street analysts research reports to find new investing and trading ideas for our readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of Wall Street’s Top analysts outlook for Key issues for Tuesday, as follows:

Anheuser-Busch InBev S.A./N.V. (NYSE:BUD) was raised to Outperform from Market Perform with a 132 price target at Bernstein.

Archer Daniels Midland Co. (NYSE:ADM) was raised to Buy from Neutral with a 50 price target at Goldman Sachs.

Carlyle Group L.P. (NASDAQ:CG) was raised to Buy from Neutral with a 28.50 price target at Citigroup.

Fennec Pharmaceuticals Inc. (NASDAQ:FENC) was started as Outperform with a 17 price target at Wedbush Securities. The firm noted that Pedmark is the 1st compound shown to prevent hearing loss in children, and it expects approval in mid-to-late Y 2019 in the United States and European Union, with peak sales potential of $225-M in those 2 regions

 

Intuit Inc. (NASDAQ:INTU) was reiterated as Outperform and the price target was raised to 195 from 185 at Credit Suisse, with the firm talking up Q-3 results and recent IRS tax filings data.

Stay tuned…

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

You must be logged in to post comments :  
CONNECT WITH